Dr. Emily Marine Leproust Ph.D.
Dr. Emily Marine Leproust is CEO and Founder of Twist Bioscience. As an early pioneer in the high-throughput synthesis and sequencing of DNA, she is disrupting the process of gene synthesis to enable the exponential growth of synthetic biology applications in multiple fields including medicine, DNA data storage, agricultural biology, and industrial chemicals. Prior to co-founding Twist Bioscience, she held escalating positions at Agilent Technologies where she architected the successful SureSelect product line that lowered the cost of sequencing and elucidated mechanisms responsible for dozens of Mendelian diseases. She also developed the Oligo Library Synthesis technology, where she initiated and led product and business development activities for the team. Emily has published over 30 peer-reviewed papers, many on applications of synthetic DNA, and is the author of numerous patents. She holds an MS in Industrial Chemistry from CPE Lyon and a Ph.D. in Organic Chemistry and Nuclear Acids Chemistry.
Year appointed: 2013